Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Teladoc Health, Inc.TDOC · Entity 1547 | Head of Research & Development | January 25, 2021 | January 27, 2021 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Teladoc Health, Inc.
Report date January 25, 2021 · Filed January 27, 2021
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | IndirectBy Yulun & Susan Wang Family Trust | 219,507 |
Reported balance
After 2021-01-25 transaction · row 1
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 1 · 2021-01-25 · Sale · Disposed 8,261 · Balance 219,507 F1: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on December 14, 2020. |
Filing footnotes · ownership attribution and instrument terms
F1: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on December 14, 2020.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| January 25, 2021 Filed Jan 27, 2021 16:02 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | SaleCommon Stock | 8,261 | $280.00 | $2,313,080.00 |
DisclosureSEC source: 0001179110-21-000871 · edgar.xml · nonDerivative · entry 1 WANG YULUN · CIK 0001055915 · Head of Research & Development 10b5-1 filing: Not disclosed Ownership: Indirect · By Yulun & Susan Wang Family Trust Disclosed balance after: 219,507 F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on December 14, 2020. Read SEC document |
| January 22, 2021 Filed Jan 25, 2021 16:01 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | SaleCommon Stock | 8,000 | $260.00 | $2,080,000.00 |
DisclosureSEC source: 0001179110-21-000811 · edgar.xml · nonDerivative · entry 1 WANG YULUN · CIK 0001055915 · Head of Research & Development 10b5-1 filing: Not disclosed Ownership: Indirect · By Yulun & Susan Wang Family Trust Disclosed balance after: 227,768 F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on December 14, 2020. Read SEC document |
| January 20, 2021 Filed Jan 22, 2021 16:00 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | SaleCommon Stock | 8,000 | $240.00 | $1,920,000.00 |
DisclosureSEC source: 0001179110-21-000775 · edgar.xml · nonDerivative · entry 1 WANG YULUN · CIK 0001055915 · Head of Research & Development 10b5-1 filing: Not disclosed Ownership: Indirect · By Yulun & Susan Wang Family Trust Disclosed balance after: 235,768 F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on December 14, 2020. Read SEC document |
| January 14, 2021 Filed Jan 19, 2021 16:02 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | SaleCommon Stock | 8,000 | $226.66 | $1,813,280.00 |
DisclosureSEC source: 0001179110-21-000671 · edgar.xml · nonDerivative · entry 1 WANG YULUN · CIK 0001055915 · Head of Research & Development 10b5-1 filing: Not disclosed Ownership: Indirect · By Yulun & Susan Wang Family Trust Disclosed balance after: 243,768 F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on December 14, 2020. Read SEC document |
| December 15, 2020 Filed Dec 16, 2020 16:02 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 4,500 | $0.00 Strike: $16.92 | $0.00 |
DisclosureSEC source: 0001179110-20-011987 · edgar.xml · derivative · entry 5 WANG YULUN · CIK 0001055915 · Head of Research & Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,865 Underlying: Common Stock · 4,500 shares Expires 2026-07-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The option vested in full on July 1, 2020. Read SEC document |
| December 15, 2020 Filed Dec 16, 2020 16:02 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 4,500 | $16.92 | $76,140.00 |
DisclosureSEC source: 0001179110-20-011987 · edgar.xml · nonDerivative · entry 3 WANG YULUN · CIK 0001055915 · Head of Research & Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,500 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 14, 2020 Filed Dec 16, 2020 16:02 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 2,500 | $0.00 Strike: $16.92 | $0.00 |
DisclosureSEC source: 0001179110-20-011987 · edgar.xml · derivative · entry 4 WANG YULUN · CIK 0001055915 · Head of Research & Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57,365 Underlying: Common Stock · 2,500 shares Expires 2026-07-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The option vested in full on July 1, 2020. Read SEC document |
| December 14, 2020 Filed Dec 16, 2020 16:02 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | SaleCommon Stock | 2,500 | $199.24 | $498,100.00 |
DisclosureSEC source: 0001179110-20-011987 · edgar.xml · nonDerivative · entry 2 WANG YULUN · CIK 0001055915 · Head of Research & Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Read SEC document |
| December 14, 2020 Filed Dec 16, 2020 16:02 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 2,500 | $16.92 | $42,300.00 |
DisclosureSEC source: 0001179110-20-011987 · edgar.xml · nonDerivative · entry 1 WANG YULUN · CIK 0001055915 · Head of Research & Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,500 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 04, 2020 Filed Dec 7, 2020 16:03 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 5,000 | $0.00 Strike: $16.92 | $0.00 |
DisclosureSEC source: 0001179110-20-011722 · edgar.xml · derivative · entry 6 WANG YULUN · CIK 0001055915 · Head of Research & Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,865 Underlying: Common Stock · 5,000 shares Expires 2026-07-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The option vested in full on July 1, 2020. Read SEC document |
| December 04, 2020 Filed Dec 7, 2020 16:03 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 1,069 | $0.00 Strike: $16.92 | $0.00 |
DisclosureSEC source: 0001179110-20-011722 · edgar.xml · derivative · entry 5 WANG YULUN · CIK 0001055915 · Head of Research & Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,069 shares Expires 2026-02-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The option vested in full on July 1, 2020. Read SEC document |
| December 04, 2020 Filed Dec 7, 2020 16:03 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | SaleCommon Stock | 5,000 | $202.00 | $1,010,000.00 |
DisclosureSEC source: 0001179110-20-011722 · edgar.xml · nonDerivative · entry 4 WANG YULUN · CIK 0001055915 · Head of Research & Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Read SEC document |
| December 04, 2020 Filed Dec 7, 2020 16:03 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 5,000 | $16.92 | $84,600.00 |
DisclosureSEC source: 0001179110-20-011722 · edgar.xml · nonDerivative · entry 3 WANG YULUN · CIK 0001055915 · Head of Research & Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 04, 2020 Filed Dec 7, 2020 16:03 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | SaleCommon Stock | 1,069 | $198.00 | $211,662.00 |
DisclosureSEC source: 0001179110-20-011722 · edgar.xml · nonDerivative · entry 2 WANG YULUN · CIK 0001055915 · Head of Research & Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Read SEC document |
| December 04, 2020 Filed Dec 7, 2020 16:03 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 1,069 | $16.92 | $18,087.48 |
DisclosureSEC source: 0001179110-20-011722 · edgar.xml · nonDerivative · entry 1 WANG YULUN · CIK 0001055915 · Head of Research & Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,069 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.